Brand Name | Status | Last Update |
---|---|---|
dimethyl fumarate | ANDA | 2024-12-23 |
dimethyl fumarate dimethyl fumarate | ANDA | 2025-04-01 |
tecfidera | New Drug Application | 2024-03-14 |
Expiration | Code | ||
---|---|---|---|
DIMETHYL FUMARATE, TECFIDERA, BIOGEN INC | |||
2023-02-05 | M-260 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Psoriasis | D011565 | EFO_0000676 | L40 | 1 | — | 1 | 1 | 1 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Psoriatic arthritis | D015535 | EFO_0003778 | L40.5 | — | — | — | — | 1 | 1 |
Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 1 | 1 |
Drug common name | Dimethyl fumarate |
INN | — |
Description | Dimethyl fumarate is an enoate ester resulting from the formal condensation of both carboxy groups of fumaric acid with methanol. Used for treatment of adults with relapsing forms of multiple sclerosis. It has a role as an immunomodulator and an antipsoriatic. It is an enoate ester, a methyl ester and a diester. It is functionally related to a methanol and a fumaric acid. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COC(=O)/C=C/C(=O)OC |
PDB | — |
CAS-ID | 624-49-7 |
RxCUI | — |
ChEMBL ID | CHEMBL2107333 |
ChEBI ID | 76004 |
PubChem CID | 637568 |
DrugBank | DB08908 |
UNII ID | — |